Durability of immune checkpoint inhibitor (ICI) response following treatment discontinuation in advanced merkel cell carcinoma (MCC).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Nova Southeastern University, Moffitt Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4400272137
